D'Agostini. C C; Palamara. A T AT; Favalli. C C; Sivilia. M M; Febbraro. G G; Bue. C C; Garaci. E E
In mice infected with flu, a mix of the antiviral drug amantadine, the immune‑boosting peptide thymosin‑alpha‑1, and a single dose of interferon helped most animals survive, cut the virus in the lungs, and restored key immune cells. This shows the combo works better than any single treatment, but it’s only an animal study, so it doesn’t directly tell people how to use it in humans yet.
Garaci. E E; Lopez. M M; Bonsignore. G G; Della Giulia. M M; D'Aprile. M M; Favalli. C C; Rasi. G G;...
A small clinical trial gave cancer patients a mix of chemotherapy drugs plus the immune‑boosting peptide thymosin‑alpha‑1 and low‑dose interferon. The combo helped shrink tumors in many patients and seemed to protect some immune cells, with side effects that were manageable. However, the study was only in advanced lung‑cancer patients, not healthy people, and it doesn’t give clear dosing or safety info for everyday use.
Rasi. G G; Silecchia. G G; Sinibaldi-Vallebona. P P; Spaziani. E E; Pierimarchi. P P; Sivilia. M M;...
In a rat study, giving the chemotherapy drug 5‑fluorouracil together with low‑dose thymosin‑alpha‑1 and interleukin‑2 shrank liver tumors from colon cancer, stopped them from spreading, improved survival, and boosted natural‑killer cell activity.
Milenkovic. L L; Lyson. K K; Aguila. M C MC; McCann. S M SM
The study shows that the peptide thymosin‑alpha‑1 can directly suppress the brain’s release of hormones that control the thyroid (TRH), stress (CRH) and growth hormone regulation (somatostatin) in a lab dish, and it does this at very tiny concentrations. However, the work was done on isolated mouse hypothalamus tissue, not in people, so we don’t know how it translates to real‑world dosing or effects.
In mice with severe infection, giving the immune‑boosting peptide thymosin‑alpha‑1 together with the steroid dexamethasone helped more of them survive. The combo worked by balancing the number of dendritic immune cells, which reduced the spread of bacteria and improved the ability to clear a second infection.
Scientists created a very sensitive lab test that can measure tiny amounts of the peptide thymosin‑alpha‑1 in blood, down to about 2 pg/ml. They found that very young children have roughly five times more of this peptide in their plasma than older people, and the test specifically detects the natural form of the peptide.
Barcia. M G MG; Castro. J M JM; Jullien. C D CD; González. C G CG; Freire. M M
The study shows that the small protein thymosin‑alpha‑1, which is the first 28 building blocks of a larger protein called prothymosin‑alpha, can be chemically modified (phosphorylated) by an enzyme called casein kinase‑2 at specific spots near its start. This modification also happens in real immune cells, suggesting it’s a natural process, but the research doesn’t tell us how to change dosing or use it differently.
Kim. Bo Hyun BH; Lee. Youn-Jae YJ; Kim. Won W; Yoon. Jung-Hwan JH; Jung. Eun Uk EU; Park. Sung Jae S...
Adding the peptide thymosin‑alpha‑1 to standard peginterferon treatment for hepatitis B did not make the therapy work better. The combined response rates were almost the same as using peginterferon alone, and side effects were similar.
Cordero. O J OJ; Sarandeses. C S CS; Nogueira. M M
Scientists labeled prothymosin alpha (ProTα) and found it sticks to immune cells using a part of the molecule that isn’t the thymosin‑alpha‑1 (Tα1) fragment, showing ProTα works differently from Tα1.
Ramachandran. R R; Katzenstein. D A DA; Winters. M A MA; Kundu. S K SK; Merigan. T C TC
In a small study of HIV patients with very low immune cells, a modified form of IL‑2 boosted CD4 counts by about a third, but adding thymosin‑alpha‑1 didn’t raise them any further. Neither treatment sparked the virus to grow, and both were well tolerated.
Naz. R K RK; Kaplan. P P; Badamchian. M M; Goldstein. A L AL
A lab test showed that the peptide thymosin‑alpha‑1 can boost human sperm’s ability to penetrate an egg‑like target, especially at a specific low dose, and that a short version of the peptide (the last 14 building blocks) works almost as well. This points to a possible new way to help men with fertility issues, but the research is still early and done in a test‑tube, not in people.
Garaci. E E; Rocchi. G G; Perroni. L L; D'Agostini. C C; Soscia. F F; Grelli. S S; Mastino. A A; Fav...
A study gave HIV patients a mix of the drug zidovudine, a protein called thymosin‑alpha‑1, and interferon‑alpha for a year. The combo was safe and led to a noticeable rise in both the number and activity of important immune cells (CD4+ T cells), more than zidovudine alone or with just one of the other agents. This suggests thymosin‑alpha‑1 can boost immune function when used with other treatments, but the research is limited to HIV patients and hasn’t been tested in healthy people.
Kaufmann. R A RA; Welch. R A RA; Mutchnick. M G MG
A small study of women undergoing IVF found that those who later had a miscarriage had lower levels of the immune‑modulating peptide thymosin‑alpha‑1 around the time of conception, while levels of a related peptide, thymosin‑beta‑4, were the same in both groups.
The paper says thymosin‑alpha‑1 is a small protein that can help the immune system’s Th1 cells work better, which may improve the body’s ability to fight cancers and infections like HIV. It’s mentioned as one of several agents that could boost immune responses when used with other immune‑modulating drugs, but the article doesn’t give specific dosing or home‑use instructions.
In pigs, giving the hormone hCG or extra testosterone makes the blood levels of thymosin‑alpha‑1 and thymosin‑beta‑4 drop, and these thymosin levels also naturally fall as the animals get older. This shows that sex hormones can influence these immune‑related peptides, but the work was done in animals, not people.
Frillingos. S S; Seferiadis. K K; Papanastasiou. M M; Baxevanis. C N CN; Frangou-Lazaridis. M M; Eco...
The study shows that when human blood monocytes are exposed to prothymosin alpha, they cut out and release the short peptide thymosin‑alpha‑1, which can help T‑cells grow. This process needs the cells to make new proteins and can be blocked by certain inhibitors. The work is done in a petri dish, not in people, so it’s more of a basic science clue than a ready‑to‑use supplement tip.
Tryphonas. H H; Luster. M I MI; White. K L KL; Naylor. P H PH; Erdos. M R MR; Burleson. G R GR; Germ...
A long‑term study in female rhesus monkeys found that low‑level exposure to the pollutant PCB (Aroclor 1254) raised several immune markers, including a dose‑dependent increase in thymosin‑alpha‑1, while other markers like TNF stayed unchanged.
Galoyan. A A AA; Shuvalova. L A LA; Davis. M T MT; Shively. J E JE; Lee. T D TD
The study found that a fragment of thymosin beta‑4 (amino acids 1‑39) strongly boosts the baseline activity of a muscle‑related enzyme (MLCK) more than thymosin alpha‑1, but the work was done in test‑tube experiments on rabbit muscle, not in people.
Hadden. J W JW; Malec. P H PH; Coto. J J; Hadden. E M EM
The study shows that in old mice, giving thymosin‑alpha‑1 by itself didn’t rebuild the shrinking thymus, but it helped boost the benefits when combined with a mix of immune‑stimulating interleukins. This suggests thymosin alone isn’t enough to reverse age‑related immune decline, though it may act as a supportive add‑on to other immune‑boosting agents.
Gupta. D D; Haldar. C C; Coeleveld. M M; Roth. J J
In rats, thymosin‑alpha‑1 was found to boost the nuclear form of the pineal gland's androgen receptor, which could influence melatonin production, but the study is basic animal work and doesn’t give human dosing or clear health benefits.